Table 2.
Study group characteristics
| Characteristic | Working patients | No reduced productivity | Reduced productivity | P value |
|---|---|---|---|---|
| total | (WPS) | (WPS) | ||
| N = 249 | N = 97 | N = 152 | ||
| Mean age [years (± SD)] | 48.9 (11.5) | 49.9 (11.7) | 48.2 (11.3) | 0.75 |
| Sex [n (%)] | ||||
| Male | 109 (43.8) | 46 (47.4) | 63 (41.4) | 0.36 |
| Female | 140 (56.2) | 51 (52.6) | 89 (58.6) | |
| Employment [n (%)] | ||||
| Full time | 166 (66,7) | 54 (55.7) | 112 (73.7) | 0.29 |
| Symptom duration | ||||
| Mean [years (SD)] | 7.3 (8.8) | 9.1 (9.7) | 6.1 (7.9) | 0.01 |
| Median [years (inner quartile range(] | 3.5 (7.9) | 5.6 (10.1) | 2.8 (6.2) | n/a |
| Diagnosis (ICD 10) [n (%)]* | ||||
| K21 | 58 (23.3) | 20 (20.6) | 38 (25.0) | 0.45 |
| K21.0 | 101 (40.6) | 43 (44.3) | 58 (38.2) | 0.36 |
| K21.9 | 66 (26.5) | 24 (24.7) | 42 (27.6) | 0.66 |
| R12 | 72 (28.9) | 29 (29.9) | 43 (28.3) | 0.89 |
| Proton pump inhibitor use [n (%)] | ||||
| Yes | 222 (89.1) | 86 (88.7) | 136 (89.5) | 0.83 |
| Histamine-receptor-2 use use [n (%)] | ||||
| Yes | 33 (13.3) | 10 (10.3) | 23 (15.1) | 0.27 |
*Multiple diagnoses possible